Clinical Trials
Attention Deficit Hyperactivity Disorder (ADHD, ADD)
Featured Studies
Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.
- Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With Attention Deficit Hyperactivity Disorder (The APS Study).
Interventional study. This study will evaluate the safety and effectiveness of extended release mixed amphetamine salts in treating preschool children with attention deficit hyperactivity disorder. Ages 36 Months-66 Months. Location in Springfield, MA.
- Atomoxetine and Parent Management Training in Treating Children With Autism and Symptoms of Attention Deficit Disorder With Hyperactivity.
Interventional study. This study will evaluate the effectiveness of the medication atomoxetine, with and without parent management training, in treating children with autism or pervasive developmental disorder not otherwise specified who have symptoms of attention deficit hyperactivity disorder. Ages 5-14. Locations in Rochester, NY; Columbus, OH; Pittsburgh, PA.
- Effectiveness of the Non-Stimulant Medication Lobeline in Improving Symptoms of Attention Deficit Hyperactivity Disorder in Adults.
Interventional study. The study will evaluate the effectiveness of the nonstimulant medication lobeline in improving symptoms of attention deficit hyperactivity disorder in adults. Ages 21-45. Location in Lexington, KY.
- Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder.
Interventional study. This study will evaluate the effectiveness of a single drug versus a combination of drugs in treating attention deficit hyperactivity disorder in children. Ages 7-14. Location in Los Angeles, CA.
- Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders.
Interventional study. This study will evaluate the effectiveness of a parent training program in improving parenting skills and reducing behavioral symptoms in young children who are at risk for developing childhood behavior disorders. Ages 22 Months-38 Months. Locations in Dorchester, MA; Jamaica Plain, MA; Leominster, MA; Southboro, MA; Westford, MA; Westwood, MA; Wilmington, MA; Woburn, MA.
- Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder.
Interventional study. This study will evaluate the effectiveness of organizational skills training in improving organizational, time management, and planning difficulties in children with attention deficit hyperactivity disorder. Ages 8-11. Locations in Durham, NC; New York, NY.
- Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy.
Interventional study. This study will evaluate the safety and effectiveness of extended release methylphenidate (XR-MPH) in treating attention deficit hyperactivity disorder (ADHD) in children with both ADHD and epilepsy. Ages 6-18. Location in Boston, MA.
- Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder.
Interventional study. This study will determine the effectiveness of integrated parent training versus standard behavioral parent training in treating depression and stress in mothers of children with attention deficit hyperactivity disorder (ADHD). Ages 6 and over. Location in College Park, MD.
- Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children.
Interventional study. This study will evaluate the effectiveness of atomoxetine in reducing the symptoms of attention deficit hyperactivity disorder (ADHD) in young children. Ages 5-6. Locations in Durham, NC; Omaha, NE; New York, NY.
- Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children.
Interventional study. This study will determine the effectiveness of stimulant and nonstimulant medication in treating the symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents. Ages 6-17. Locations in Chicago, IL; New York City, NY.
- Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children.
Interventional study. This study will first examine the cognitive and behavioral differences in children who have an autism spectrum disorder (ASD) and who do and do not have additional symptoms of attention deficit hyperactivity disorder (ADHD). The study will then examine the effectiveness of a range of doses of methylphenidate in improving cognitive and behavioral outcomes in children with both ASD and ADHD. Ages 7-12. Location in Houston, TX.
- Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings.
Interventional study. This study will determine the effectiveness of educating pediatricians about attention deficit hyperactivity disorder treatment guidelines in improving child behavior and pediatricians' adherence to medication guidelines. Ages 6-11. Location in Chicago, IL.
- A Clinic-Based Prevention Program for Families of Depressed Mothers.
Interventional study. This study will assess the effectiveness of the "Keeping Families Strong" program (KFS) in avoiding or delaying the onset of psychiatric disorders among children with depressed mothers. Ages 8 and over. Location in Baltimore, MD.
